long-term fertility drug users, women who remain nulligravid after fertility treatment, women with BRCA1 or BRCA2 mutations, and women with borderline ovarian tumours are definitely at risk, but it’s not with every patient
You should talk to your doctor regarding this as she is the person who knows about your history and treatment best
Answered2023-11-23 03:55:21
Let others know if this answer was helpful